bf/NYSE:EBS_icon.jpeg

COM:EMERGENTBIOSOLUTIONS

Emergent BioSolutions

  • Stock

Last Close

8.88

21/11 21:00

Market Cap

487.34M

Beta: -

Volume Today

1.28M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
30.26M
-
36.74M
21.42%
62.87M
71.12%
51.78M
17.65%
82.59M
59.52%
62.70M
24.09%
54.50M
13.08%
305.10M
459.82%
230.90M
24.32%
-223.80M
196.93%
-760.50M
239.81%
depreciation and amortization
18.96M
-
32.45M
71.18%
35.34M
8.88%
38.23M
8.19%
42.57M
11.36%
62.20M
46.11%
110.70M
77.97%
114.50M
3.43%
123.80M
8.12%
143.30M
15.75%
129.10M
9.91%
deferred income tax
13.86M
-
16.49M
19.01%
3.46M
79.00%
5.19M
49.83%
3.26M
37.21%
8.60M
163.88%
-1.60M
118.60%
-2.40M
50%
46.90M
2,054.17%
-19M
140.51%
-8.90M
53.16%
stock based compensation
11.24M
-
12.83M
14.16%
15.85M
23.53%
18.48M
16.59%
15.21M
17.67%
23.20M
52.50%
26.70M
15.09%
51M
91.01%
42.40M
16.86%
45.10M
6.37%
23.10M
48.78%
change in working capital
24.14M
-
13.54M
43.91%
-65.90M
586.70%
-45.45M
31.04%
53.72M
218.20%
-119.10M
321.69%
-39.90M
66.50%
8.80M
122.06%
-156.40M
1,877.27%
500K
100.32%
-70.30M
14,160%
accounts receivables
35.46M
-
21.41M
39.63%
-64.35M
400.64%
-22.45M
65.12%
-4.81M
78.57%
-94.20M
1,858.42%
-8.20M
91.30%
49M
697.56%
-48.20M
198.37%
114.70M
337.97%
-21.60M
118.83%
inventory
518K
-
4.23M
716.41%
-11.26M
366.30%
-9.03M
19.85%
6.07M
167.21%
-1.90M
131.32%
-16.70M
778.95%
-83.20M
398.20%
-44M
47.12%
-51.90M
17.95%
600K
101.16%
accounts payables
-551K
-
-9.28M
1,584.03%
4.75M
151.18%
-14.79M
411.46%
16.13M
209.08%
-7M
143.39%
16.50M
335.71%
19.80M
20%
-2.50M
112.63%
-14M
460.00%
10.60M
175.71%
other working capital
-11.28M
-
-2.81M
75.05%
4.96M
276.26%
813K
83.61%
36.33M
4,369.13%
-16M
144.04%
-31.50M
96.88%
23.20M
173.65%
-61.70M
365.95%
-48.30M
21.72%
-59.90M
24.02%
other non cash items
-1.49M
-
261K
117.54%
-7.15M
2,841.00%
-14.73M
105.97%
10.78M
173.14%
4.20M
61.03%
37.60M
795.24%
59M
56.91%
33.50M
43.22%
19.80M
40.90%
481.20M
2,330.30%
net cash provided by operating activities
96.97M
-
112.32M
15.83%
44.46M
60.42%
53.49M
20.31%
208.14M
289.14%
41.80M
79.92%
188M
349.76%
536M
185.11%
321.10M
40.09%
-34.10M
110.62%
-206.30M
504.99%
investments in property plant and equipment
-42.02M
-
-30.67M
27.01%
-44.81M
46.10%
-76.26M
70.17%
-54.83M
28.10%
-72.10M
31.50%
-86.90M
20.53%
-141M
62.26%
-225M
59.57%
-115.80M
48.53%
-51.60M
55.44%
acquisitions net
-25.87M
-
-179.38M
593.31%
-650K
99.64%
-827.70M
-
270.20M
-
purchases of investments
sales maturities of investments
other investing activites
-195.10M
-
2.60M
101.33%
-10M
484.62%
-10M
0%
-265.50M
-
-6.30M
97.63%
net cash used for investing activites
-67.89M
-
-210.05M
209.38%
-45.46M
78.36%
-76.26M
67.74%
-249.93M
227.75%
-897.20M
258.98%
-96.90M
89.20%
-151M
55.83%
-225M
49.01%
-381.30M
69.47%
212.30M
155.68%
debt repayment
-62.77M
-
-62M
1.23%
-20M
-
-2.80M
86%
-116.30M
4,053.57%
-387.10M
232.85%
-35.90M
90.73%
-33.80M
5.85%
-543.40M
1,507.69%
common stock issued
8.20M
-
31.60M
285.37%
15.90M
49.68%
5M
68.55%
10.20M
104%
common stock repurchased
-213K
-
-200K
6.10%
-100K
50%
-33.08M
-
-100K
99.70%
-7.40M
7,300%
-13.80M
86.49%
-106M
668.12%
-82.10M
22.55%
dividends paid
-800.00K
-
-17.80M
2,125.00%
-15.90M
10.67%
-5M
68.55%
other financing activites
71.60M
-
261.07M
264.63%
33.55M
87.15%
-18.64M
155.56%
1.68M
108.99%
791.60M
47,131.50%
80.40M
89.84%
456.60M
467.91%
900K
99.80%
597.10M
66,244.44%
-2.50M
100.42%
net cash used provided by financing activities
8.61M
-
198.87M
2,209.27%
33.45M
83.18%
-18.64M
155.73%
-51.40M
175.74%
788.70M
1,634.41%
-35.90M
104.55%
69.50M
293.59%
-141M
302.88%
481.20M
441.28%
-535.70M
211.33%
effect of forex changes on cash
-14K
-
21K
250%
-150K
814.29%
129K
186%
-27K
120.93%
-200K
640.74%
400K
300%
-1M
350%
-300K
70%
500K
266.67%
-1.20M
340%
net change in cash
37.67M
-
101.16M
168.53%
32.30M
68.07%
-41.28M
227.82%
-93.22M
125.82%
-66.90M
28.24%
55.60M
183.11%
453.50M
715.65%
-45.20M
109.97%
66.30M
246.68%
-530.90M
900.75%
cash at beginning of period
141.67M
-
179.34M
26.59%
280.50M
56.41%
312.80M
11.51%
271.51M
13.20%
179.30M
33.96%
112.40M
37.31%
168M
49.47%
621.50M
269.94%
576.30M
7.27%
642.60M
11.50%
cash at end of period
179.34M
-
280.50M
56.41%
312.80M
11.51%
271.51M
13.20%
178.29M
34.33%
112.40M
36.96%
168M
49.47%
621.50M
269.94%
576.30M
7.27%
642.60M
11.50%
111.70M
82.62%
operating cash flow
96.97M
-
112.32M
15.83%
44.46M
60.42%
53.49M
20.31%
208.14M
289.14%
41.80M
79.92%
188M
349.76%
536M
185.11%
321.10M
40.09%
-34.10M
110.62%
-206.30M
504.99%
capital expenditure
-42.02M
-
-30.67M
27.01%
-44.81M
46.10%
-76.26M
70.17%
-54.83M
28.10%
-72.10M
31.50%
-86.90M
20.53%
-141M
62.26%
-225M
59.57%
-115.80M
48.53%
-51.60M
55.44%
free cash flow
54.95M
-
81.64M
48.59%
-353K
100.43%
-22.77M
6,350.42%
153.31M
773.30%
-30.30M
119.76%
101.10M
433.66%
395M
290.70%
96.10M
75.67%
-149.90M
255.98%
-257.90M
72.05%

All numbers in (except ratios and percentages)